Fny Investment Advisers, LLC Pharma Cyte Biotech, Inc. Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 10, 2023
BUY
$2.39 - $3.07 $74,329 - $95,477
31,100 New
31,100 $90,000
Q2 2022

Jul 12, 2022
SELL
$1.99 - $2.33 $87,114 - $101,998
-43,776 Reduced 74.11%
15,290 $34,000
Q1 2022

Apr 25, 2022
BUY
$1.91 - $2.77 $112,816 - $163,612
59,066 New
59,066 $135,000

Others Institutions Holding PMCB

# of Institutions
30
Shares Held
932K
Call Options Held
0
Put Options Held
0
View Full List

About PharmaCyte Biotech, Inc.

PMCB Quotes by TradingView
  • Ticker PMCB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,750,100
  • Market Cap $35.1M
  • Description
  • PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...
More about PMCB
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email